Partial characterization of a 52 kDa CsA/FK506/rapamycin binding protein

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Understanding the mechanism of action for immunosuppressive drugs such as cyclosporine (CsA), FK506, and rapamycin requires identifying their specific cellular binding proteins.
• Cellular proteins interacting with these drugs are crucial targets for elucidating their biological effects.

Purpose of the Study:

• To isolate and characterize cellular proteins that specifically bind to immunosuppressive drugs.
• To investigate the functional and catalytic activities of a newly identified 52 kDa binding protein (BP).

Main Methods:

• Isolation and partial characterization of a 52 kDa binding protein (BP) from calf thymus.
• Assays for cis-trans peptidyl prolyl isomerase activity using peptide substrates.
• Enzyme activity assays including kinase, phosphatase, protein kinase C, and LCK tyrosine kinase regulation.
• Microsequencing of the 52 kDa BP for sequence comparison.

Main Results:

• A 52 kDa BP was isolated and found to have minimal cis-trans peptidyl prolyl isomerase activity.
• The 52 kDa BP demonstrated the ability to inhibit cyclic AMP-dependent, protein kinase-mediated phosphorylation of histones and casein.
• The protein exhibited no intrinsic kinase activity and did not modulate protein kinase C or LCK tyrosine kinase activity.
• Microsequencing revealed the 52 kDa BP to be a unique protein with no previously characterized sequence homology.

Conclusions:

• The identified 52 kDa BP is a novel protein that binds to immunosuppressive drugs.
• This unique protein plays a role in regulating phosphorylation pathways, distinct from known isomerase or kinase activities.
• Further characterization of this 52 kDa BP may reveal new therapeutic targets or pathways related to immunosuppression.